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Abstract 
Artificial cells can shed new light on the molecular basis for life and hold potential for new 
chemical technologies. Inspired by how nature dynamically regulates its membrane 
compartments, we aim to repurpose the endosomal sorting complex required for transport 
(ESCRT) to generate complex membrane architectures as suitable scaffolds for artificial cells. 
Purified ESCRT-III components perform topological transformations on giant unilamellar 
vesicles (GUVs) to create complex “vesicles-within-a-vesicle” architectures resembling the 
compartmentalisation in eukaryotic cells. Thus far, the proposed mechanisms for this 
activity are based on how assembly and disassembly of ESCRT-III on the membrane drives 
deformation. Here we demonstrate the existence of a negative feedback mechanism from 
membrane mechanics that regulates ESCRT-III remodelling activity. Intraluminal vesicle (ILV) 
formation removes excess membrane area, increasing tension, which in turn suppresses 
downstream ILV formation. This mechanism for in vitro regulation of ESCRT-III activity may 
also have important implications for its in vivo functions.   
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Introduction 
The biological cell is fundamentally a highly complex chemical reactor, where 
compartmentalisation of its chemical processes is essential for complex functions 
(Ausländer et al., 2017). Eukaryotic organisms contain membrane-bound cellular sub-
compartments, which allow distinct chemical environments to exist within the cell, such 
that otherwise incompatible chemistries can be maintained and utilised, e.g. ATP synthesis 
in the mitochondria and protein degradation in lysosomes (Satori et al., 2013). The manifold 
capabilities of a cell in the synthesis of complex biomolecules, sensing and response to its 
environment are all desirable functionalities to emulate within a synthetic system (Chen and 
Silver, 2012). Therefore chemical technologies that provide control over the formation of 
multicompartment membrane architectures are fundamental to artificial cell engineering 
(Buddingh’ and van Hest, 2017; Xu et al., 2016). 
 
While microfluidic technologies have been developed that allow fixed multicompartment 
membrane architecture to be formed (Deshpande and Dekker, 2018; Elani et al., 2018), 
natural cells can dynamically change their compartmentalised architectures. To emulate this 
dynamic nature within an artificial cell system, we take inspiration from biology by 
repurposing protein complexes in vitro that natively remodel membrane structures (Beales 
et al., 2015). The “vesicles-within-a-vesicle” architecture we aspire to recreate in an artificial 
cell bears resemblance to a cellular membrane-bound organelle, the multivesicular body 
(MVB). In eukaryotic cells, MVBs are formed by the encapsulation of biomolecular cargo into 
intraluminal vesicles (ILVs) within endosomes (Hanson and Cashikar, 2012). This membrane 
remodelling event is performed by the ESCRT (endosomal complex required for transport) 
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machinery (Hurley, 2008). This activity lends itself to the possibility of using ESCRT in the 
construction of multicompartment artificial cells in vitro (Marklew et al., 2018). 
  
Human ESCRT drives multiple key membrane-remodelling processes, such as multivesicular 
body formation, cell division, exosome formation, HIV budding, plasma and nuclear 
envelope membrane repair (Christ et al., 2017; Hurley, 2015). In yeast, ESCRT is responsible 
for cargo sorting in the endosomal pathway and also for nuclear pore complex quality 
control (Thaller and Lusk, 2018). The ESCRT machinery responsible for transmembrane 
receptor sorting via the endosomal pathway comprises of ESCRT-0, ESCRT-I and ESCRT-II 
protein complexes, which capture ubiquitinated transmembrane cargo at the late 
endosome membrane and initiate membrane invagination (Frankel and Audhya, 2018). The 
central membrane remodelling complex is ESCRT-III, a highly conserved set of proteins in 
eukaryotes, and the AAA+ ATPase Vps4 (Figure 1A) (Adell et al., 2016, p. 4; Monroe and Hill, 
2016). In Saccharomyces cerevisiae, ESCRT-III consists of a core machinery comprised of the 
Vps20, Snf7, Vps24 and Vps2 subunits. ESCRT-III-mediated membrane budding and scission 
of vesicles occurs with a unique topology, whereby the membrane is pushed away from the 
cytosol (Schöneberg et al., 2017). The initial membrane deformation performed by ESCRT-II, 
recruits ESCRT-III subunits and drives the formation of ESCRT-III filaments on the membrane 
(Henne et al., 2013). In vitro studies on flat surface-supported membranes have shown that 
ESCRT-III forms spirals that are proposed to behave like springs, storing elastic energy, which 
deform the membrane upon release (Chiaruttini et al., 2015). The observation of this spiral 
structure informs the mechanical rationale for membrane deformation and scission in many 
of the proposed mechanisms where either a spiral (Chiaruttini and Roux, 2017), cone 
(Agudo-Canalejo and Lipowsky, 2018), or dome (Fabrikant et al., 2009; Różycki et al., 2012) 
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structure made by ESCRT-III stabilises and subsequently drives scission of the ILV bud neck. 
This process is made possible by the action of the ATPase Vps4, which has been shown to 
catalyse ESCRT-III activity by maintaining the dynamics of complex assembly and 
disassembly (Mierzwa et al., 2017; Adell et al., 2017; Schöneberg et al., 2018). 
  
ESCRT-II recruits the ESCRT-III subunit Vps20 to form a complex with affinity for regions of 
membrane curvature (Fyfe et al., 2011).  In turn, Vps20 nucleates the formation of Snf7 
spirals that are capped at the growing end by a Vps24-Vps2 complex (Teis et al., 2008) Vps2 
recruits the ATPase Vps4 through the interaction between its MIM (MIT-Interacting Motif) 
motif with the MIT (Microtubule Interacting and Transport) domain of Vps4 (Obita et al., 
2007; Stuchell-Brereton et al., 2007)). Intraluminal vesicle (ILV) formation by ESCRT-
II/ESCRT-III can be reconstituted in vitro with a GUV-based bulk-phase uptake assay. The 
activity of a minimal ESCRT-III / Vps4 system in artificial vesicle systems was first 
demonstrated by Wollert et al (Wollert et al., 2009) where ILVs were generated in GUV 
parent vesicles and observed by microscopy. Additionally there are examples of more 
minimal sets of ESCRTs inducing ILV formation in vitro, such as Vps20/ Snf7 only (Avalos-
Padilla et al., 2018), and some minimal activity with moderate concentrations of Snf7 alone 
(Marklew et al., 2018), suggesting further scope for simplification of the system in a 
technological context.  
  
The reconstitution of ESCRT activity in vitro opens the possibility of achieving finer control of 
ILV formation in artificial systems. Therefore we initially set out to investigate the relative 
stoichiometry of ESCRT-III components to underpin their influence on the size and number 
of ILVs that form within individual GUVs (Figure 1B). Interestingly, our initial experiments 
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reveal wide variation in ILV size and number between different GUVs within an individual 
experiment (Figure 2A). Membrane mechanics are considered to be the likely source of 
these differences due to variability in tension across a single GUV population. Modulating 
membrane tension could therefore provide a further means to exert control over ILV 
formation and will also be investigated in this study.  
  
Here we report on how changing the relative stoichiometry of the ESCRT-III subunits and the 
mechanical properties of the membrane regulate the size and number of ILVs formed in a 
GUV-based bulk-phase uptake assay (Figure 1B). These findings reveal a mechanism that 
regulates ESCRT activity in vitro and provide further insight into how they may function in 
vivo.  
 
Results 
‘Passive’ and ‘active’ membrane budding and scission by ESCRT. 
ESCRT components were overexpressed and purified using appropriate plasmids (see 
supplemental Transparent Methods and Figure S1). We have quantified ESCRT activity using 
the bulk phase uptake assay as described by Wollert and Hurley (Wollert et al., 2009), 
introducing a systematic variation in the ratio of key ESCRT-III in the reaction. In this assay, 
GUVs with an ‘endosome-like’ lipid composition (Wollert et al., 2009) are incubated with the 
ESCRT-II complex (Vps22, Vps36, Vps25), and the core ESCRT-III subunits Vps20, Vps24, Vps2 
and Snf7. Prior to the addition of proteins, a membrane-impermeable, fluorescent dextran 
(Mr ~ 5 kDa, Cascade blue labelled) is added to the GUV suspension to establish whether 
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newly formed ILVs have encapsulated bulk phase (Figure 2A). Confocal microscopy (Figure 
2B) is used to assess the number of ILVs and the observed diameter of each ILV is recorded 
(observed diameter may not be the true maximum diameter of the ILV). Only ILVs visibly 
containing dextran fluorescence are counted, as this confirms their formation following 
addition of the proteins. The number of ILVs and the volume of the GUV lumens in the 
image is then used to calculate the number of ILVs per unit volume, the unit volume being 
taken as that of an average 20 μm diameter GUV, hence ‘ILVs per GUV volume equivalent’. 
Controls containing only osmotically balanced buffer and fluorescent dextran give a minimal 
background level of intraluminal vesicles formed within the experimental period (see ‘no 
protein control’ in figure legends). The process of ILV formation observed in the absence of 
Vps4 and ATP is referred to as ‘passive – ESCRT only’, or simply ‘passive’ since it identifies 
budding events that are independent of energy input from ATP hydrolysis, dependent only 
on ESCRT-III. In the context of in vivo ESCRT activity, this process would be considered to be 
off-pathway as recent evidence supports the requirement of the ATPase activity of Vps4 for 
efficient membrane deformation and scission (Adell et al., 2014; Mierzwa et al., 2017; Adell 
et al., 2017). A second fluorescent dextran (Mr ~ 10 kDa, AlexaFluor 488 labelled) can be 
added to this GUV population, followed by 20 minutes incubation with Vps4 and ATP.MgCl2. 
Newly formed ILVs in these conditions will contain blue and green fluorescence. The process 
of ILV formation driven by ATP hydrolysis by Vps4 is referred to as ‘active − + Vps4/ATP’, or 
simply ‘active’. Both passive and active formation of ILVs, induced by the action of ESCRTs, 
are observed in GUVs (Figure 2 B (ii)). 
 
ILV formation efficiency reaches a maximum for a specific molar ratio of Snf7 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Snf7 oligomerisation is central to ESCRT-III activity, with more Snf7 units present in the 
active complex than other ESCRTs (Wollert and Hurley, 2010). While the relationship 
between ESCRT-III subunit stoichiometry and activity has been studied in vivo (Adell et al., 
2017), this is currently not well understood in vitro.  
 
Bulk-phase encapsulation assays are performed at a range of Snf7 concentrations (5-250 
nM), and maintain a fixed concentration (10 nM) of each of the remaining ESCRT-II and 
ESCRT-III components (Figure 3). For both passive and active processes, 50 nM Snf7 
provides the greatest activity in terms of number of ILVs observed, with no improvement at 
250 nM. Interestingly, this is comparable to Snf7 being present at approximately up to five 
times the concentration of other ESCRT-III components in yeast (Adell et al., 2017; Wollert 
and Hurley, 2010).  
 
A similar number of ILVs form during the passive and active processes, which may indicate 
‘recycling’ of the membrane bound ESCRT components once, and their reassembly into a 
similar number of active complexes. However other explanations are plausible and this may 
be complicated by changes and variability in GUV membrane tension in the second “active” 
round of ILV formation. ILV size is also found to be generally consistent across the full 
concentration range, with the only significant differences being found between active and 
passive processes at the 10 nM and 50 nM Snf7 concentrations, where ATP-fuelled “active” 
formation favours slightly smaller ILVs, on average. Below 10 nM and above 50 nM Snf7 may 
be too little or too much protein with respect to other ESCRT-III components to produce 
fully competent complexes.  
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The role of Vps4 ATPase activity in the active process is confirmed by the control 
experiments in Figure 3 (ii). Omission of Vps4, or replacement of ATP with a non-
hydrolysable ATP analogue (Adenylyl-imidodiphosphate) both significantly supress the 
active formation process. Nonetheless a few AlexaFluor488 labelled dextran containing ILVs 
are observed in each case. This low background rate of encapsulation may be the result of 
mechanical disturbance of the sample solution during the addition of the second round of 
proteins / ATP. Vps4 itself may possess some innate activity in the absence of ATP, which 
may account for the slightly greater number of ‘green’ ILVs found in that case, but the 
difference between the ‘NH-ATP’ and ‘no Vps4’ controls is not found to be significant. Figure 
3. (ii) ‘ATP’ contains the full set of proteins plus ATP.MgCl2, at the same concentrations as 
Figure 3. (i) ’50 nM’ but a higher number of ILVs per GUV volume equivalent is observed in 
these experiments. This variability is ascribed to variation in protein quality between 
expressed batches: all data presented on a single plot is obtained with the same batch of 
protein. This means that there are small differences between some of the absolute values 
and associated errors of ILVs formed under nominally identical conditions within different 
figures of the papers as these were independent experiments performed with different 
protein batches.  
 
Membrane tension is the dominant factor in ILV formation efficiency and size. Protein 
stoichiometry effects are minimal. 
Vps20 bridges ESCRT-III to ESCRT-II and is involved in the nucleation of Snf7 oligomers onto 
endosomal membranes, in vivo (Fyfe et al., 2011; Henne et al., 2012). Vps20 possesses an N-
terminal myristoylation that facilitates binding to membranes in general (Im et al., 2009), 
the ESCRT-II complex activates Vps20 by a mechanism including binding to the subunit 
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Vps25 and generating initial invagination of the membrane (Boura et al., 2012). Activation of 
Vps20 leads to the recruitment and assembly of Snf7 and other downstream ESCRT-III 
proteins (Fyfe et al., 2011; Im et al., 2009).  Nucleation is a critical step in the formation of 
ILVs, therefore Vps20 stoichiometry was examined for its influence on ILV size and number. 
Varying the Vps20 concentration relative to that of other ESCRT-III components should 
provide different numbers of potential nucleation sites for ESCRT-III assembly. A higher 
number of nucleation sites should result in a similarly higher number of ILVs, provided that 
there are sufficient other ESCRT-III components to form functional assemblies at each of 
these sites. The ‘dilution’ of the available ESCRT-III components across a larger number of 
nucleation sites may also result in smaller Snf7 assemblies, which may give rise to smaller 
ILVs, if there is a relationship between the size of the complex and the resulting 
ILV.  Furthermore, these experiments are performed with both high and low membrane 
tension GUVs, where low tension GUVs are subjected to an osmotic relaxation protocol, to 
assess the influence of membrane mechanics.  
  
Across a 50-fold variation in concentration, the relative stoichiometry of Vps20 to other 
ESCRT sub-units does not appear to have a significant effect on the number of ILVs observed 
(Figure 4 ‘Number’). While a reduction in membrane tension results in 3-4 times the 
number of ILVs formed per unit volume for both active and passive activity. Neither Vps20 
stoichiometry nor membrane tension yield a significant effect on ILV size (Figure 4 ‘Size’). 
 
In a recent model of ESCRT-III assembly (Chiaruttini et al., 2015; Mierzwa et al., 2017; 
Saksena et al., 2009), Vps24 and Vps2 bind to the growing end of the Snf7 filament 
providing a limiting signal to filament growth by terminating Snf7 spiral elongation. Vps2 
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recruits the ATPase Vps4 to the ESCRT-III assembly to recycle the proteins and allow for 
multiple rounds of ILV formation. However competing models have also recently suggested 
the formation of mixed Snf7, Vps2, Vps24 filaments where each protein has a different 
preferred curvature in the spiral assembly (Chiaruttini and Roux, 2017). In this experiment, 
we test how varying Vps24 stoichiometry influences the efficiency of ILV formation, which 
may occur either by premature termination of ESCRT-III filament growth or alternatively, by 
modulating the stored elastic energy in spiral ESCRT complexes. 
 
Overall, we see a weak dependence of Vps24 stoichiometry on the efficiency of ILV 
formation in a similar fashion to what was observed for Vps20 (Figure 5), where the effects 
of membrane tension dominate the actions induced by stoichiometric changes of Vps24 
with a 3-5 fold increase in ILV number in the low tension regime.  However at the lowest 
Vps24 concentration (5 nM), there appears to be an inhibitory effect on ILV number in the 
low tension GUV population, but in high tension samples, no Vps24 concentration effect on 
number is observed. GUVs in the low tension regime also display an effect of Vps24 
stoichiometry on the size of ILV produced, with the lowest Vps24 concentration producing 
significantly larger mean ILV diameter for both active and passive formation, suggestive that 
increased capping of the complex by Vps24 favours smaller ILV sizes. Furthermore, we see a 
significant increase in ILV size in the low tension regime in these experiments, indicative that 
lower mechanical resistance to membrane deformation facilitates more membrane, on 
average, being removed from the parent GUV in an individual ILV formation event.  
 
Taken together, our data show that membrane tension plays a major role in regulating 
ESCRT-driven ILV formation. 
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Membrane tension negatively regulates ILV formation by ESCRT-III 
The deformation of a membrane during ESCRT-induced ILV budding would encounter 
greater mechanical resistance on higher tension membranes. The energetic input to achieve 
this may be derived from the assembly of ESCRT-III components, primarily Snf7 filaments, 
which are directly implicated in driving membrane budding. While the role of Vps4, a 
mechanoenzyme, has been suggested to be in the scission of ILV buds from their parent 
membrane through the disassembly of stabilising Snf7 filaments, some published results 
have suggested that ESCRT complexes only exert measurable forces on membranes during 
ATP-driven Vps4 activity (Schöneberg et al., 2018). 
 
Our data reveals a strong, significant dependence of the efficiency of ILV formation on 
membrane tension, implying typical membrane tensions in GUVs are sufficient to compete 
with the energetic driving force of membrane deformation exerted by the ESCRT complex. 
Therefore, regardless of the mechanism or magnitude of the force exerted, there must exist 
a maximum membrane tension that is able to undergo ESCRT-induced ILV budding. A 
relationship between ILV size and membrane tension is also plausible as the magnitude of 
membrane deformation that can be achieved during budding may be modulated by tension. 
Any such effects resulting from resistance to membrane deformation will necessarily be 
concurrent with any effects resulting from transient membrane curvature. As assemblies of 
ESCRT-II and Vps20 are known to have an increased affinity for regions of membrane 
curvature (Fyfe et al., 2011), the transient curvature changes from membrane undulations 
that are more pronounced in low tension membranes may also enhance the affinity of 
ESCRT-II/ Vps20 complexes for the membrane.  
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Interestingly, we find that the suppression of ILV formation is of a similar extent in both the 
passive and active processes. This implies that the inhibitory mechanism is not significantly 
dependent on Vps4 and ATP. Therefore, we hypothesize that either (i) the complex exerts a 
similar magnitude of deformation force on the membrane in both the active and passive 
processes, or (ii) the increased recruitment of ESCRTs to the membrane due to enhanced 
undulatory curvature at low membrane tension is the dominant factor. Since a recent report 
shows measurable membrane deformation forces only occur due to Vps4 activity 
(Schöneberg et al., 2018), this lends favour to the latter interpretation. Interestingly, 
simulations have previously reported analogous tension-dependent assembly of N-BAR 
domains on membranes (Simunovic and Voth, 2015). 
 
Flicker spectroscopy experiments are used to quantify the distribution of membrane 
tensions () in GUV populations in our low tension and high tension regimes, before and 
after incubation with ESCRT proteins (Figures 4, S2 and S3.). 
 
GUVs are found to have high membrane tension following initial electroformation. Addition 
of the ESCRT complex resulted in a narrowing of the distribution of membrane tensions 
towards the high tension end of the initial distribution (Figure S2). This implies that the 
lower tension vesicles within the initial population have increased their tension due to their 
interaction with ESCRTs. This is likely due to ILVs forming within the less tense vesicles of the 
high tension population and a significant number of GUVs where no ILVs have formed are 
observed in these samples, suggestive that their tension might be too high for the ESCRT 
complex to act upon them. Some GUVs in these samples are too tense to be quantified by 
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the full flicker analysis as the data for higher q modes became noisy due to their small 
amplitude. Therefore the mean square amplitudes of the longest wavelength undulatory 
mode (n=3) is analysed as a proxy for membrane tension where smaller mean square 
amplitudes correspond to a higher membrane tension (Amjad et al., 2017).  
 
The mechanical coupling between membrane tension and ESCRT function is most evident in 
the low tension regime. As expected, the osmotic relaxation procedure reduces the mean 
membrane tension by about an order of magnitude and also narrows the range of tension 
values across the population (Figure 6 ‘Relaxed GUVs’). As discussed above, the error of the 
full analysis of flicker spectrum increases at higher tension, therefore we present both the 
absolute tension measurement and the mean-square amplitude of the third mode in Figure 
6 to demonstrate that both analysis methods demonstrate the same data trends. Similarly, 
due to increasing tension after protein addition, bending modulus (κ) values could only be 
reliably obtained for osmotically relaxed GUVs before the addition of the ESCRT proteins. 
Relaxed GUVs were found on average to have κ = 24.5 kBT, which agrees with those typically 
reported for POPC / cholesterol membranes (Dimova, 2014; Henriksen et al., 2006).  
 
ESCRT activity increases membrane tension. Further flicker spectra are obtained after 
incubation with ESCRT proteins, using our standard procedure (50 nM Snf7, 10 nM ESCRT-II, 
Vps20, Vps24, Vps2, Vps4, 1 µM ATP.MgCl2, 20 minutes incubation), (Figure 6. ‘Relaxed 
GUVs + ESCRT-III’). The mean tension after ILV formation increases to an intermediate value 
between the ‘Tense’ GUVs and those that have been osmotically relaxed ‘Pre-protein’. This 
increase in membrane tension will act to make further ILV formation more difficult, 
providing a mechanism of negative feedback to self-regulate ESCRT activity. Notably, the 
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‘post-protein’ tension range does not reach the highest tension values observed in the initial 
electroformed GUV population, suggesting that in these cases, ILV formation is not limited 
by the membrane mechanics and further ILV formation is likely possible upon addition of 
more ESCRT-III or further active recycling of the existing components. 
 
Discussion 
Here we have shown that ESCRT-III activity is regulated by the tension of the membrane 
substrate, using an in vitro model membrane system. Our work recapitulates ESCRT-
mediated membrane budding and scission in the GUV system and shows that membrane 
tension significantly dominates over any attempt to control ILV formation by varying the 
ratio of the ESCRT-III assembly reaction. Increased membrane tension through removal of 
excess membrane surface area, provides a negative feedback mechanism that eventually 
suppresses membrane remodelling by ESCRT-III.  
 
Based on a model where individual ESCRT constituents promote nucleation (Vps20), growth 
(Snf7) and termination (Vps24) of the ESCRT filaments, we hypothesized that variation of 
relative ratio between subunits may affect the efficiency of ILV formation and ILV size. 
Nonetheless, we observed minimal effects on ILV formation efficiency and size when varying 
Vps20 and Vps24 concentration across a 50-fold concentration range. Therefore ILV formation 
under these conditions is weakly dependent on Vps20 and Vps24. This suggests that either: (i) 
membrane mechanics strongly dominates the effects of nucleation and termination in our 
experimental regime, or (ii) there is a narrow range of stoichiometric composition where 
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functional ESCRT complexes form, giving rise to a weak dependence on the concentration of 
a single component. We consider the latter scenario to be most likely given that ILV 
formation in relaxed vesicles is not limited by membrane mechanics at the typical protein 
concentrations used (Figure 6). 
 
Mechanistic models of ESCRT activity revolve around the formation of circular or spiral 
structures on membranes that drive membrane invagination (Chiaruttini et al., 2015), 
constricting and stabilising ILV bud necks (Adell et al., 2014) prior to scission by disassembly 
of the oligomer (Hurley and Hanson, 2010). Nonetheless, membrane curvature drives the 
recruitment of specific ESCRT subunits (Castro-Gomes et al., 2014) and membrane 
undulations, amplified at low tension, have been implicated in promoting self-assembly of 
other curvature-generating proteins at the membrane (Simunovic and Voth, 2015). Hence, a 
more complete model for ESCRT-mediated remodelling activity includes the membrane as 
an active participant. Here, we have elucidated a regulatory role for membrane mechanics 
in preventing runaway over-activity of the ESCRT complex via a negative feedback 
mechanism. 
 
Minimal model systems provide clues to the biological mechanisms and interactions of the 
reconstituted components, allowing hypotheses to be generated about the more complex 
biological scenario. ESCRTs perform a wide variety of membrane remodelling functions 
within the cell (Hurley, 2015) with some of these responding directly to changes in 
membrane tension, such as membrane abscission during cytokinesis, whereby relaxation of 
membrane tension promotes recruitment of ESCRT-III to the intercellular bridge (Lafaurie-
Janvore et al., 2013). In the endocytic pathway, fusion of endosomes may provide excess 
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membrane that lowers tension and could therefore facilitate generation of internal vesicles 
by ESCRT-III, suggestive of a homeostatic relationship between endosomal fusion and 
formation of vesicles within the MVB (Skjeldal et al., 2012). ESCRTs also play an important 
role in plasma and nuclear envelope membrane repair, where a loss in tension caused by 
membrane impairment could contribute to the rapid recruitment of the complex to the site 
of damage. Notably, the plasma membrane structures known as caveolae, and their 
associated proteins, act as a store of excess membrane area that provides a stress-
responsive buffer of membrane tension, and their involvement in numerous signalling 
pathways demonstrates the sensitivity of cellular processes to changes in membrane 
tension (Parton and del Pozo, 2013). 
 
Membrane tension could provide a general means of regulating ESCRT activity. Plasma 
membrane tension has been reported in the low tens of µN m
-1
 range (Sens and Plastino, 
2015), which is above the range of values observed in our GUV membranes. This may 
suggest that ESCRT remodelling activity is generally inhibited until local events at the 
membrane lower tension and promote ESCRT reactions. Cellular membranes lacking 
cytoskeleton support, such as blebs, have tensions typically in the µN m
-1
 range (Sens and 
Plastino, 2015), matching the higher end of our measured values. Accordingly, our data 
show a significant increase in efficiency of ESCRT activity (as measured by efficiency of ILV 
formation) associated with a change in mean tension from 4.8 µN m
-1
 to 0.6 µN m
-1
. These 
represent physiologically relevant values of membrane tensions supporting the inference of 
our model for ESCRT activity regulation by membrane mechanics not only in vitro but also in 
vivo.  
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Our primary interest is to develop the ESCRT proteins as a means of directing 
compartmentalisation in artificial cell systems, ultimately to enable dynamic control over 
their compartmentalised structures. While the fundamental ILV-forming activity of ESCRT-III 
in GUVs is well established, our intention is to determine means of exerting finer control 
over compartment parameters, such as size, number and cargo encapsulation. Membrane 
tension provides a promising control parameter to regulate ILV formation in GUVs and is 
suggestive of strategies that would allow multiple rounds of ILV formation to provide 
numerous distinct artificial organelles within GUV artificial cells.  
 
Limitations of the Study 
Our study clearly demonstrates that membrane tension acts to regulate ILV formation by 
ESCRT in giant vesicle artificial cells. This tension-control is most evident in the number of 
ILV compartments that are formed. We found that there is little control over the size of the 
ILV compartments, hence alternative approaches are required if compartment size would be 
an important parameter to regulate. Stoichiometry of ESCRT components appears to have a 
weak effect on ILV formation efficiency in our experimental conditions, however, this does 
not completely rule out stoichiometric control as this may exist in a different concentration 
regime. The parameter space for varying the concentrations and relative stoichiometries of 
ESCRT components is extremely broad and unfeasible to fully cover in a single study. We 
propose that the regulation of ESCRT activity by membrane mechanics observed in vitro will 
have relevance to understanding of ESCRT function in vivo. Naturally, further studies 
designed to elucidate this phenomenon in the complex cellular environment are required to 
confirm these predictions. 
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Figure legends. 
 
Figure 1. Experimental design rationale. A: ESCRT-III drives a number of cellular processes 
that generate new membrane-bound compartments. Notably, multi-vesicular body (MVB) 
genesis, this  process  that  can  be  reconstituted  in  vitro  using  synthetic  vesicles (Wollert 
et al., 2009) B: ESCRT-III  may  deform  membranes  by  assembling  into  ordered  
supramolecular  ‘springs’  (depicted  as  blue  spirals). Protein stoichiometry and membrane 
tension were identified as variables that may allow finer control over the size and number of 
Intraluminal vesicles (ILVs) produced in vitro. Nucleation of Snf7 spiral filaments by Vps20 
may provide a means to control the number of ILVs, while Vps24 may act as a terminator or 
‘cap’ of Snf7 filament growth, limiting ILV size. High membrane tension may impede ILV 
formation by resisting membrane deformation, potentially impacting both the size and 
number of ILVs formed.  
 
Figure 2: A.1: Confocal microscope image of a cross section (3.1 μm) through a number of 
GUVs incubated with ESCRT-II, Vps20, Vps24, Vps2 (10 nM) and Snf7 (50 nM). A number of 
different ILV sizes are observed in the field of view (1-5). Red: Rhodamine-PE, Green: 
AlexaFluor-488-labelled dextran. Scale bar 10 μm). A.2: ILV morphology, a range of 
commonly observed ILV states. a. Many similarly sized ILVs plus buds, b. Few ILVs of varying 
dimensions, c. ‘Stalled’ ILV buds with few or no co-incident free-floating ILVs, d. Unusually 
large ILVs ~5 μm diameter. Red: Rhodamine-PE, Green: AlexaFluor-488-labelled dextran. All 
scale bars 10 μm.  B(i): Schematic of the ILV formation procedure. Cascade blue labelled 
dextran was added to GUVs in Tris buffer (2), immediately followed by ESCRT-II, Vps20, 
Vps24, Vps2 (10 nM) and Snf7 (50 nM) (3). After a 20 minute incubation period, AlexaFluor 
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488-labelled dextran was added (4), immediately followed by Vps4 (10 nM) and ATP.MgCl2 
(1 μM) (5). Thereby, ILVs containing only cascade blue dextran can be identified as having 
formed before the addition of Vps4 and ATP, and those that contain both dyes, must have 
formed after addition. B(ii): Confocal image of a GUV containing ILVs formed by active (ATP 
driven) and passive (no ATP) processes. Cascade Blue-labelled dextran (blue channel) was 
added immediately before incubation with ESCRT-II, Vps20, Vps24, Vps2 (10 nM) and Snf7 
(50 nM). AlexaFluor488-labelled dextran (green channel) was added immediately before the 
addition of Vps4 (10 nM), and ATP.MgCl2 (1 μM) followed by a further period of incubation. 
White arrows indicate passively formed ILVs, yellow arrows indicate actively formed ILVs 
Membranes labelled with lissamine-rhodamine-PE (red channel). 40x objective, scale bar = 
10 μm. 
 
Figure 3. Snf7 stoichiometry bulk phase encapsulation assay. ILV counting and 
characterisation by confocal microscopy. ILVs containing fluorescent dye in their lumens 
after the addition of ESCRT proteins. (i) Number: Number of ILVs per GUV volume 
equivalent; the number of ILVs observed per volume of a 20 µm diameter sphere. Size: 
Mean diameter of the observed ILVs. Blue: ‘Passive’ formation. ILVs containing cascade 
blue-dextran, after simultaneous addition of ESCRT-II, Vps20, Vps24, and Vps2 (10 nM), and 
Snf7 at the concentration stated on the x-axis, but before the addition of 10 nM Vps4 and 1 
µM ATP.MgCl2. Green: ‘Active’ formation. ILVs containing AlexaFluor488-dextran observed 
after the addition of 10 nM Vps4 and 1 µM ATP.MgCl2. Corresponding size histograms for 
each data point are presented in Supplementary Figure S4. (ii): ATPase activity controls: 
Number of ‘actively’ formed ILVs (containing both blue and green dyes) per GUV volume 
equivalent, ‘No protein’: GUVs with no addition of protein incubated with both dextran dyes 
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for the same time as the protein containing experiments, ‘no Vps4’ all proteins added (50 
nM Snf7, 10 nM others) + 1 µM ATP.MgCl2 with Vps4 omitted, ‘NH-ATP’ all proteins added 
(50 nM Snf7, 10 nM  others), + 1 µM of MgCl2  and the non-hydrolysable ATP (‘NH-ATP’) 
analogue Adenylyl-imidodiphosphate, ‘ATP’: all proteins (50 nM Snf7, 10 nM others) + 1 µM 
ATP.MgCl2. Osmotically relaxed vesicles were used in all experiments. Data are represented 
as the mean value +/- the standard error of the mean. Each data point is averaged from n=3 
independent experiments, each containing 100+ independent GUVs. Significance testing: 
one-way ANOVA with Bonferroni test, one-tailed, * p < 0.05, ** p < 0.01, *** p < 0.001. No 
ESCRT control background rate = 0.067 ILVs per unit volume (standard error: 0.016). 
 
Figure 4. Vps20 stoichiometry bulk phase encapsulation assay. ILV counting and 
characterisation by confocal microscopy. ILVs containing fluorescent dye in their lumens 
after the addition of ESCRT proteins. Number: Number of ILVs per GUV volume equivalent. 
Size: Mean diameter of the observed ILVs. Blue: High membrane tension GUVs, Red: Low 
membrane tension GUVs. Passive: ILVs observed after simultaneous addition of ESCRT-II, 
Vps24, and Vps2 (10 nM), Snf7 (50 nM) and Vps20 at the concentration stated on x-axis, but 
before the addition of 10 nM Vps4 and 1 µM ATP.MgCl2. Active:  After the addition of 10 
nM Vps4 and 1 µM ATP.MgCl2. Data are represented as the mean value +/- the standard 
error of the mean. . Each data point is averaged from n=3 independent experiments, each 
containing 100+ independent GUVs. Significance testing: one-way ANOVA with Bonferroni 
test, one-tailed, * p < 0.05, ** p < 0.01, *** p < 0.001. No ESCRT control background rate for 
low tension GUVs = 0.067 ILVs per unit volume (standard error: 0.016), for high tension 
GUVs = 0.054 ILVs per unit volume (standard error: 0.017). Corresponding size histograms 
for each data point are presented in Supplementary Figure S5. 
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Figure 5. Vps24 stoichiometry bulk phase encapsulation assay. ILV counting and 
characterisation by confocal microscopy. ILVs containing fluorescent dye in their lumens 
after the addition of ESCRT proteins. Number: Number of ILVs per GUV volume equivalent. 
Size: Mean diameter of the observed ILVs. Blue: High membrane tension GUVs, Red: Low 
membrane tension GUVs. Passive: ILVs observed after simultaneous addition of ESCRT-II, 
Vps20, and Vps2 (10 nM), Snf7 (50 nM) and Vps24 at the concentration stated on x-axis, but 
before the addition of 10 nM Vps4 and 1 µM ATP.MgCl2. Active:  After the addition of 10 
nM Vps4 and 1 µM ATP.MgCl2. Data are represented as the mean value +/- the standard 
error of the mean. Each data point is averaged from n=3 independent experiments, each 
containing 100+ independent GUVs. Significance testing: one-way ANOVA with Bonferroni 
test, one-tailed, * p < 0.05, ** p < 0.01, *** p < 0.001.  No ESCRT control background rate 
for low tension GUVs = 0.067 ILVs per unit volume (standard error: 0.016), for high tension 
GUVs = 0.054 ILVs per unit volume (standard error: 0.017). Corresponding size histograms 
for each data point are presented in Supplementary Figure S6. 
 
Figure 6: (i) The distribution of membrane tension σ in GUV samples. (ii) Distributions for 
the values of the amplitude of the third vibrational mode for the same GUVs. ‘Tense’ GUVs 
were those that were not exposed to an osmotic gradient. The membrane tension of 
osmotically ‘relaxed’ GUVs was measured before (Pre-protein) and after (Post-protein) the 
addition of the ESCRT proteins to assess the effect of ILV formation on membrane tension. 
Box descriptions: ■ – mean values, line termini correspond to the minimum and maximum 
observed values, the upper and lower bounds of the boxes correspond to the 75
th
 and 25
th
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percentile values respectively and the inner line, the 50
th
 percentile. n=10. See also Figure 
S2 and Figure S3. 
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Highlights 
• ESCRT proteins are used to create compartmentalised artificial cell architectures. 
• In vitro ESCRT activity is weakly dependent on stoichiometry of Vps20 or Vps24. 
• ESCRT function is strongly regulated by membrane tension. 
• Membrane tension provides a negative feedback mechanism to attenuate remodelling. 
